SCHEDULE 13G

Statement of Beneficial Ownership

Werewolf Therapeutics, Inc. Filed 2026-09-21 Acc 0001732748-26-000003

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-09-22 S-4 Registration Statement - Business Combination
2026-09-21 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

External

SEC EDGAR (opens in new tab)